Rare diseases
Investigational molecules
Locations
Study on the Safety and Tolerability of Guanabenz in Children with Vanishing White Matter Disease
The NetherlandsStudy of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia
The NetherlandsStudy of Nivolumab for Patients with Esophageal Cancer Undergoing Active Surveillance After Chemoradiation
The NetherlandsStudy of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency
The NetherlandsStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
The NetherlandsStudy of NMD670 tablets to improve muscle strength in adults with TYPE 3 spinal muscular atrophy who can walk
The NetherlandsStudy on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis
The NetherlandsStudy of SGM-101 fluorescent imaging agent to guide surgery in patients with pancreatic cancer who received prior treatment
The NetherlandsStudy on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids
The NetherlandsStudy on the Safety and Effects of RLYB212 in Pregnant Women at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
The NetherlandsStudy on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer
The NetherlandsStudy of ACP-017 and Pembrolizumab for Patients with Advanced or Metastatic Cancer
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
